Lumida
/AARD
⌘K
Aardvark Therapeutics Inc

Aardvark Therapeutics Inc

AARD
$5.13USD+2.40%+0.12 today

MARKET CAP

112.3M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $6

52W RANGE

$3
$18

AI Summary

Stalk
Buy NowMedium

AARD exhibits a medium-term uptrend characterized by higher highs and higher lows since mid-June, supported by rising EMAs. A recent Bearish Exhaustion pattern and oversold RSI suggest sellers are losing control, setting up a pullback into the 9/20/50 EMA zone. This pullback offers a favorable entry aligned with the bullish Stage 2 advance. We recommend buying now on the interaction with intermediate EMAs, with risk defined by a break below those levels.

  • Unique Prader-Willi niche; ARD-101 success could unlock unmet demand
  • $73.9M cash runway to late 2027; R&D spend cut to $10.5M
  • FDA’s full clinical hold halts ARD-101 HERO/OLE trials, delaying launch
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICTREND
Sales, Adj.
YoY %
P / Sales
EV / Sales
Gross Profit, Adj.
YoY %
Margin %
EV / Gross Profit
EBITDA, Adj.
YoY %
Margin %
EV / EBITDA
EBIT
YoY %
Margin %
EV / EBIT
Net Income
YoY %
Net Margin
EPS (GAAP)
YoY %